功能性结肠疾病3种治疗方案的成本-效果分析  

Cost-effectiveness Analysis of Three Therapeutic Schemes for Functional Colonic Diseases

作　　者：田鹤[1] 杨同聚 

机构地区：[1]山东省邹城市人民医院药剂科,邹城市273500

出　　处：《中国药房》2002年第2期89-90,共2页China Pharmacy

摘　　要：目的 :探讨不同药物治疗方案对同一疾病所产生的经济效果。方法 :根据文献选择148例功能性结肠疾病患者 ,随机分为3组 ,分别给予胶体酒石酸铋、双歧杆菌、西沙必利治疗 ,运用药物经济学的成本 -效果分析方法进行评价。结果与结论OBJECTIVE:To discuss the economical effects of different medications on the treatment of same illness.METH_ODS:148 cases of functional colonic diseases were collected from literature and were randomly divided into three groups;colloidal bismuth artrate was given to the first group,bifidobacterium to the second and cisapride to the last.Data was evaluated using the pharmacoeconomic cost-effectiveness analysis.RESULTS:Colloidal bismuth artrate was the best medicine to treat functional colonic diseases.CONCLUSION:The pharmacoeconomics play an important role in guiding the physician to choose the best therapeutic regimen in making clinical decision,so as to gain the maximal benefit with the minimal cost.

关 键 词：成本-效果分析 药物经济学 功能性结肠疾病 治疗 

分 类 号：R574.620.5[医药卫生—消化系统]